UPNEEQ®

Most patients in clinical trials had a lift in their eyelids in as little as 2 hours

• 84% of patients had some form of improvement
• 74% of patients had more than a 50% improveme

In clinical trials, Upneeq helped patients with acquired ptosis see more—on the first day of treatment!

• 87.8% of patients had some form of improvement
• 40.8% of patients had at least a 50% improvement on Day 14 (2 hours after applying Upneeq)

 In clinical trials, Upneeq was proven to be safe and effective when used as directed.

Common side effects (seen in 1-5% of patients) included eye inflammation, eye redness, dry eye, blurred vision, instillation site pain, eye irritation, and headache

Upneeq is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse.

Patients with reduced blood flow to the brain or heart, or patients who experience eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome), should use care when taking Upneeq. Call your doctor immediately if you feel your symptoms may be getting worse.

Upneeq may increase the risk of eye pressure due to fluid buildup (angle-closure glaucoma) in patients with untreated narrow-angle glaucoma. Call your doctor immediately if you feel increased pressure in your eye after using Upneeq.

Do not let the tip of the Upneeq vial touch your eye or any other surface. This can help prevent eye injury or contamination. Each Upneeq vial is for one-time use and should be discarded after being used